|
Dear
colleagues, we are very pleased to announce the joint user
meeting between Molecular Discovery and AB SCIEX. This meeting will show the new features of MetaSite, Mass-MetaSite, WebMetabase from Molecular Discovery as well as Metabolite Pilot WP from ABSCIEX, practical hands on sessions on these software with the experts and presentations from users on how they enhance their workflows by using our software. The meeting is addressed to ADME, Metabolite Identification experts and users of Metabolite Pilot/MetaSite-MassMetaSite-WebMetabase users, and will be held at the Molecular Discovery facilities in Perugia, Italy, on the 15th and 16th of May 2014. The number of places are limited, please, contact us as soon as possible Ismael Zamora (ismael[at]moldiscovery[dot]com) Gary Impey (gary[dot]impey[at]absciex[dot]com) The meeting program and the location details are available here: http://www.moldiscovery.com/blog/wp-content/uploads/2014/04/MD-ABSCIEX-jointMeeting2014.pdf Kind regards, Simon Dr. Simon Cross Snr Scientist & Product Manager Molecular Discovery Ltd Email: simon[at]moldiscovery[dot]com Molecular Discovery provides robust, high-quality and innovative computational methods addressing pharmaceutical needs in the field of drug discovery, including methods for virtual screening, lead optimisation, ADME modelling and metabolism research. Molecular Discovery software products offer calculation of accurate Molecular Interaction Fields for structure-based design (GRID), water prediction for structure-based design (FLAP), ligand-based and structure-based virtual screening (FLAP), pharmacophore elucidation (FLAP), metabolism prediction (MetaSite), metabolite identification (Mass-MetaSite), scaffold hopping (SHOP), pKa prediction (MoKa), 3D-QSAR modeling (FLAP, Pentacle) to improve efficiency in modern drug discovery. More information can be found on the main page: http://www.moldiscovery.com/ |